Young L - Search Results

1

Impact of the COVID-19 pandemic on cancer care in Ireland - Perspectives from a COVID-19 and Cancer Working Group.

O'Reilly S, Kathryn Carroll H, Murray D, Burke L, McCarthy T, O'Connor R, Kilty C, Lynch S, Feighan J, Cloherty M, Fitzpatrick P, Falvey K, Murphy V, Jane O'Leary M, Gregg S, Young L, McAuliffe E, Hegarty J, Gavin A, Lawler M, Kavanagh P, Spillane S, McWade T, Heffron M, Ryan K, Kelly PJ, Murphy A, Corrigan M, Redmond HP, Redmond P, Walsh PM, Tierney P, Zhang M, Bennett K, Mullooly M. O'Reilly S, et al. Among authors: young l. J Cancer Policy. 2023 Jun;36:100414. doi: 10.1016/j.jcpo.2023.100414. Epub 2023 Feb 24. J Cancer Policy. 2023. PMID: 36841473 Free PMC article. Review.

2

Global characterization of the SRC-1 transcriptome identifies ADAM22 as an ER-independent mediator of endocrine-resistant breast cancer.

McCartan D, Bolger JC, Fagan A, Byrne C, Hao Y, Qin L, McIlroy M, Xu J, Hill AD, Gaora PÓ, Young LS. McCartan D, et al. Among authors: young ls. Cancer Res. 2012 Jan 1;72(1):220-9. doi: 10.1158/0008-5472.CAN-11-1976. Epub 2011 Nov 9. Cancer Res. 2012. PMID: 22072566 Free PMC article.

3

Altered Steroid Milieu in AI-Resistant Breast Cancer Facilitates AR Mediated Gene-Expression Associated with Poor Response to Therapy.

Creevey L, Bleach R, Madden SF, Toomey S, Bane FT, Varešlija D, Hill AD, Young LS, McIlroy M. Creevey L, et al. Among authors: young ls. Mol Cancer Ther. 2019 Oct;18(10):1731-1743. doi: 10.1158/1535-7163.MCT-18-0791. Epub 2019 Jul 9. Mol Cancer Ther. 2019. PMID: 31289138

4

Interaction of developmental transcription factor HOXC11 with steroid receptor coactivator SRC-1 mediates resistance to endocrine therapy in breast cancer [corrected].

McIlroy M, McCartan D, Early S, O Gaora P, Pennington S, Hill AD, Young LS. McIlroy M, et al. Cancer Res. 2010 Feb 15;70(4):1585-94. doi: 10.1158/0008-5472.CAN-09-3713. Epub 2010 Feb 9. Cancer Res. 2010. PMID: 20145129

5

Metastatic progression with resistance to aromatase inhibitors is driven by the steroid receptor coactivator SRC-1.

McBryan J, Theissen SM, Byrne C, Hughes E, Cocchiglia S, Sande S, O'Hara J, Tibbitts P, Hill AD, Young LS. McBryan J, et al. Cancer Res. 2012 Jan 15;72(2):548-59. doi: 10.1158/0008-5472.CAN-11-2073. Epub 2011 Nov 22. Cancer Res. 2012. PMID: 22108824

6

An investigation of Sigma-1 receptor expression and ligand-induced endoplasmic reticulum stress in breast cancer.

Borde P, Cosgrove N, Charmsaz S, Safrany ST, Young L. Borde P, et al. Among authors: young l. Cancer Gene Ther. 2023 Feb;30(2):368-374. doi: 10.1038/s41417-022-00552-4. Epub 2022 Nov 9. Cancer Gene Ther. 2023. PMID: 36352093

7

Correction to: An investigation of Sigma-1 receptor expression and ligand-induced endoplasmic reticulum stress in breast cancer.

Borde P, Cosgrove N, Charmsaz S, Safrany ST, Young L. Borde P, et al. Among authors: young l. Cancer Gene Ther. 2023 Feb;30(2):389. doi: 10.1038/s41417-022-00579-7. Cancer Gene Ther. 2023. PMID: 36539529 No abstract available.

8

Dynamic epi-transcriptomic landscape mapping with disease progression in estrogen receptor-positive breast cancer.

Keelan S, Ola M, Charmsaz S, Cocchiglia S, Ottaviani D, Hickey S, Purcell S, Bane F, Hegarty A, Doherty B, Sheehan K, Hudson L, Cosgrove N, Roux B, Laine M, Greene G, Varešlija D, Hill AK, Young L. Keelan S, et al. Among authors: young l. Cancer Commun (Lond). 2023 May;43(5):615-619. doi: 10.1002/cac2.12407. Epub 2023 Jan 20. Cancer Commun (Lond). 2023. PMID: 36670046 Free PMC article. No abstract available.

9

Inverse relationship between ER-beta and SRC-1 predicts outcome in endocrine-resistant breast cancer.

Myers E, Fleming FJ, Crotty TB, Kelly G, McDermott EW, O'higgins NJ, Hill AD, Young LS. Myers E, et al. Among authors: young ls. Br J Cancer. 2004 Nov 1;91(9):1687-93. doi: 10.1038/sj.bjc.6602156. Br J Cancer. 2004. PMID: 15477868 Free PMC article.

10

HOXC11-SRC-1 regulation of S100beta in cutaneous melanoma: new targets for the kinase inhibitor dasatinib.

deBlacam C, Byrne C, Hughes E, McIlroy M, Bane F, Hill AD, Young LS. deBlacam C, et al. Among authors: young ls. Br J Cancer. 2011 Jun 28;105(1):118-23. doi: 10.1038/bjc.2011.193. Epub 2011 Jun 7. Br J Cancer. 2011. PMID: 21654685 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,023 results

Search Page